On the heels of Johnson & Johnson multi-modality drug discovery collaboration last month, Isomorphic Labs has now published benchmark results for its unified AI drug …
Read More
Takeda has entered a multi-year agreement with Iambic Therapeutics to deploy Iambic’s AI-driven small molecule discovery platform across oncology, gastrointestinal, and inflammation programs. The deal …
Read More
Generate Biomedicines, a Flagship Pioneering-founded antibody platform company, has filed for an initial public offering as part of a growing wave of biotech listings in …
Read More
Phylo, a Stanford spin-out, has just launched as an applied lab focused on agentic AI for biomedical research. Alongside the launch, the team announced Biomni …
Read More
Inductive Bio placed first in the OpenADMET-ExpansionRx blind challenge with its Beacon models, a large-scale industry competition for ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) …
Read More
The modern obesity drug race has been defined by one word: incretins. Blockbuster GLP-1 receptor agonists from companies like Novo Nordisk and Eli Lilly have …
Read More
